Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05622799 · ClinicalTrials.gov registry record · NA
Mind-Body Medicine Training for Incarcerated Men and Women
A NA study, sponsored by The Center for Mind-Body Medicine.
- Completed
- Registry status
- NA
- Development phase
- 46
- Enrollment target
NCT05622799: Completed NA study, sponsored by The Center for Mind-Body Medicine.
NCT05622799 is a NA study that has completed, run by The Center for Mind-Body Medicine. The registered enrollment target is 46 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05622799, a NA study, has completed, sponsored by The Center for Mind-Body Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 46 participants
- Enrollment target
Study Summary
The goal of this study is to learn about how effective a Mind-Body Medicine Training Program is for prisoners. The main questions it aims to answer are: 1. Does the training program increase resilience? 2. Does the training program reduce depression, anxiety, and/or stress? 3. Does the training program increase optimism? 4. Does the training program increase prisoners' belief that they can have better coping skills? 5. Does the training program increase a sense of meaning in life? 6. Does the training program increase a sense of life purpose? Participants will attend a 2-part mind-body medicine training program (4 days for each part) and will fill out questionnaires before the training, after the training and 6 months after the training. They will also participate in group interviews after the training and 6 months after the training.
Primary Outcome
The CD-RISC is a validated, self-report instrument assessing resilience over the last month. The CD-RISC consists of 25 questions that are rated on a 5-point scale with higher scores representing greater resilience. Change = After the 8 day training score- Baseline score; Follow-up score - After the 8 day training score; and Follow-up Score - Baseline score
Interventions
- BEHAVIORAL Mind-Body Medicine Training Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2022-11-21 |
| Est. Completion | 2024-02-19 |
| Phase | NA |
What the finished NCT05622799 record still lists
NCT05622799 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 46 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which Mind-Body Medicine Training Program is the first listed.
NCT05622799 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05622799 about?
NCT05622799 is a clinical study titled "Mind-Body Medicine Training for Incarcerated Men and Women". The goal of this study is to learn about how effective a Mind-Body Medicine Training Program is for prisoners. The main questions it aims to answer are: 1. Does the training program increase resilience? 2. Does the training program reduce depression, anxiety, and/or stress? 3. Does the training pro...
What is the current status of trial NCT05622799?
This trial is currently completed. It is a NA study. The enrollment target is 46 participants. The study started on 2022-11-21. Estimated completion is 2024-02-19.
What interventions are being tested in trial NCT05622799?
The interventions under investigation include: Mind-Body Medicine Training Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT05622799?
This trial is sponsored by The Center for Mind-Body Medicine, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05622799's enrollment target sits among peer trials
46 1402nd of 2000 higher than 590 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01890590 · 46 participants · NA
A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma
- NCT03191149 · 46 participants · Phase 2
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change
- NCT03510208 · 46 participants · Phase 1
Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery
- NCT04048278 · 46 participants · Early Phase 1
Lidocaine Infusion in Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI